Histone Modification Marks Strongly Regulate CDH1 Promoter in Prostospheres as A Model of Prostate Cancer Stem Like Cells.
CDH1
Cancer Stem Cells
Histone Modification
Methylation
Prostate Cancer
Journal
Cell journal
ISSN: 2228-5806
Titre abrégé: Cell J
Pays: Iran
ID NLM: 101566618
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
15
01
2018
accepted:
02
10
2018
entrez:
3
3
2019
pubmed:
3
3
2019
medline:
3
3
2019
Statut:
ppublish
Résumé
Cadherin-1 ( In this experimental study, we isolated PCSLCs using cell surface marker and prostaspheroid formation, respectively. The cells isolated from both methods were characterized and then the levels of H3K4me2, H3K27me3, H3K9me2/3 and H3K9ac as well as DNAmet were assessed in The CD44 Our results suggest that slight decrease of DNAmet of the CpG island in
Identifiants
pubmed: 30825285
doi: 10.22074/cellj.2019.5702
pmc: PMC6397603
doi:
Types de publication
Journal Article
Langues
eng
Pagination
124-134Informations de copyright
Copyright© by Royan Institute. All rights reserved.
Déclaration de conflit d'intérêts
There is no conflict of interest in this study.
Références
Prostate. 1999 May 15;39(3):166-74
pubmed: 10334105
Mol Cancer. 2004 Mar 22;3:9
pubmed: 15035667
Mol Cancer. 2004 Apr 26;3:12
pubmed: 15109395
J Natl Cancer Inst. 2005 Jan 19;97(2):103-15
pubmed: 15657340
Nat Rev Cancer. 2006 Feb;6(2):107-16
pubmed: 16491070
J Cell Mol Med. 2006 Jan-Mar;10(1):100-25
pubmed: 16563224
Cell. 2006 Apr 21;125(2):315-26
pubmed: 16630819
Nat Genet. 2007 Apr;39(4):457-66
pubmed: 17334365
Nat Rev Genet. 2007 Apr;8(4):286-98
pubmed: 17339880
Cancer Res. 2007 Apr 1;67(7):3153-61
pubmed: 17409422
Nature. 2007 Aug 2;448(7153):553-60
pubmed: 17603471
Plant Cell. 2008 Feb;20(2):259-76
pubmed: 18263775
Cell Stem Cell. 2007 Sep 13;1(3):286-98
pubmed: 18371363
Oncogene. 2008 Dec 11;27(58):7274-84
pubmed: 18806826
Cell Stem Cell. 2009 Jan 9;4(1):80-93
pubmed: 19128795
Immunity. 2009 Jan 16;30(1):155-67
pubmed: 19144320
PLoS One. 2009;4(3):e4687
pubmed: 19262738
Nat Rev Genet. 2009 May;10(5):295-304
pubmed: 19308066
Carcinogenesis. 2010 Jan;31(1):27-36
pubmed: 19752007
PLoS One. 2010 Feb 10;5(2):e9150
pubmed: 20161773
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a003129
pubmed: 20457567
Urol Oncol. 2012 May-Jun;30(3):314-8
pubmed: 20843707
BMC Genomics. 2010 Nov 25;11:669
pubmed: 21108828
Science. 2011 Feb 4;331(6017):593-6
pubmed: 21233348
Curr Protoc Toxicol. 2011 Feb;Chapter 22:Unit 22.2
pubmed: 21400686
Circulation. 2011 May 17;123(19):2145-56
pubmed: 21576679
BMC Gastroenterol. 2011 Jun 14;11:71
pubmed: 21669008
Mol Cancer. 2011 Jul 29;10:94
pubmed: 21801380
Mol Oncol. 2012 Dec;6(6):620-36
pubmed: 23141800
Acta Pharmacol Sin. 2013 Jun;34(6):732-40
pubmed: 23685952
Cell Mol Biol Lett. 2014 Mar;19(1):23-36
pubmed: 24363164
Epigenomics. 2014;6(4):415-26
pubmed: 25333850
PLoS One. 2015 Jun 25;10(6):e0130118
pubmed: 26110651
Int J Mol Sci. 2015 Nov 17;16(11):27433-49
pubmed: 26593898
Pharmacol Ther. 2016 Feb;158:71-90
pubmed: 26706243
Cancers (Basel). 2016 Jan 05;8(1):null
pubmed: 26742077
Stem Cell Res. 2016 May;16(3):597-606
pubmed: 27010655
PLoS One. 2016 Jun 03;11(6):e0156839
pubmed: 27258544
Stem Cells Int. 2017;2017:8629234
pubmed: 28690641
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7416-9
pubmed: 7543680